Regulator warns consumers to beware of faulty COVID-19 tests

*The US Food and Drug Administration has issued an alert to inform consumers, patients and healthcare providers about unreliable COVID-19 tests with a commonly used Curative SARS-Cov-2 test

Alexander Davis | ConsumerConnect

In regard to a risk of false results, mainly false-negative results with the Curative SARS-Cov-2 test, the United States (US) Food and Drug Administration (FDA) has issued an alert to inform consumers, patients and healthcare providers about problems with a commonly used COVID-19 test. Specifically, the agency warns that there is a risk of false results, particularly false-negative results, with the Curative SARS-Cov-2 test.

The regulatory agency stated that patients getting a false negative could face delayed treatment and run the risk of spreading the virus to others, since the patient would have no reason to take precautions in the first place.

Photo Credit: Cochrane.Org

The lack of treatment could allow the symptoms to worsen before the patient finally seeks treatment, said the FDA.

It said in its alert to the public that “to reduce the risk of false-negative results, it is important to perform the test in accordance with its authorisation and as described in the authorised labelling, e.g., the Fact Sheet for Healthcare Providers.

“When the test is not performed in accordance with its authorisation or as described in the authorised labelling, there is a greater risk that the results of the test may not be accurate.”

Meanwhile, the Coronavirus (COVID-19) tally compiled by Johns Hopkins University indicates that the total confirmed cases in the US as of January 9 stand at 21,617,462 with 365,882 deaths in the country.

Likewise, the total global cases are put at 88,339,935 with a total number of global deaths estimated at 1,904,122.

Kindly Share This Story